Company: NCEL
Filing Date: 2025-10-29
Form Type: 6-K
Source: 0001213900-25-103226
Chunk: 1

Company: NewcelX Ltd.
Filing Date: 2025-10-29
Form: 6-K
Chunk 1
---

kind of Kadimastem Ordinary Shares against issuance of new common shares of the Company to be issued to Kadimastem shareholders pursuant
to the Exchange Ratio under the Merger Agreement (the “Capital Increase”); (2) a reduction of the par value of each common
share, preferred share, and preferred participation certificate, together with the corresponding Capital Increase, as a preparatory measure
for the share consolidation; (3) a consolidation of each of the common shares, preferred shares and preferred participation certificates
at a ratio of 1:10 (the “Reverse Split”); and (4) a change of the Company’s name to NewcelX Ltd. Each of the Proposals
was approved at the Meeting.

The
Company will file its Amended and Restated Articles of Association, with the commercial registry of the Canton of Zurich, Switzerland,
reflecting the increase of the new share capital, to be effective as of October 30, 2025, following which the Company will have a registered
share capital consisted of: (A) (i) a total share capital of CHF 282,908.80, divided into 5,533,183 common shares, par value CHF 0.05
each, and 124,993 preferred shares, par value CHF 0.05 each, and (ii) a total participation capital of CHF 3,032.40, divided into 60,648
preferred participation certificates, par value CHF 0.05 each; (B) a capital band with an upper limit of CHF 428,911.80 and a lower limit
of CHF 142,970.60, which may be effected by issuing up to 2,859,412 fully paid registered common shares, par value CHF 0.05 each; and
(C) conditional share capital consisted of (i) a maximum of 450,000 fully paid in registered common shares, par value CHF 0.05 each which
amounts to CHF 22,500, and (ii) a maximum amount of CHF 120,470.60 through the issuance of not more than 2,409,412 registered common shares,
par value CHF 0.05 each. The foregoing description of the Amended and Restated Articles of Association is qualified in its entirety by
reference to the Amended and Restated Articles of Association filed as Exhibit 99.1 hereto, which is incorporated herein by